Treatment of multidrug-resistant tuberculosis during pregnancy: Long-term follow-up of 6 children with intrauterine exposure to second-line agents

Clinical Infectious Diseases

Volumn 40, Issue 11, 2005, Pages 1689-1692

  Drobac, Peter C ^a,b   Del Castillo, Hernan ^c   Sweetland, Annika ^b   Anca, Genaro ^d   Joseph, J Keith ^a,b   Furin, Jennifer ^a,b   Shin, Sonya ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b PARTNERS IN HEALTH   (United States)

^c INSTITUTO NACIONAL DE SALUD DEL NIÑO   (Peru)

^d SOCIOS EN SALUD   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CAPREOMYCIN; CIPROFLOXACIN; CLOFAZIMINE; CYCLOSERINE; ETHAMBUTOL; ISONIAZID; KANAMYCIN; OFLOXACIN; PROTIONAMIDE; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; BREAST FEEDING; FEMALE; HUMAN; MALE; MYCOBACTERIUM TUBERCULOSIS; PERINATAL DRUG EXPOSURE; PREGNANCY; PRENATAL EXPOSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE TRANSMISSION, VERTICAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; MYCOBACTERIUM TUBERCULOSIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; TIME FACTORS; TUBERCULOSIS;

EID: 19344373221     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/430066     Document Type: Article

References (30)

1. World Health Organization (WHO). Anti-tuberculosis drug resistance in the world: third global report. WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Geneva: WHO, 2004.
2. Ormerod P. Tuberculosis in pregnancy and the puerperium. Thorax 2001; 56:494-9.
3. Margono F, Mroueh J, Garely A, et al. Resurgence of active tuberculosis among pregnant women. Obstet Gynecol 1994; 83:911-4.
4. Iseman MD. Treatment of multidrug-resistant tuberculosis. N Engl J Med 1993; 329:784-91.
5. Centers for Disease Control and Prevention (CDC). Treatment of tuberculosis. American Thoracic Society, CDC, and Infectious Diseases Society of America. MMWR 2003; 52(RR-11):1-77.
6. Shin S, Guerra D, Rich M, et al. Treatment of multidrug-resistant tuberculosis during pregnancy: a report of 7 cases. Clin Infect Dis 2003; 36:996-1003.
7. Lessnau KD, Qarah S. Multidrug-resistant tuberculosis in pregnancy: case report and review of the literature. Chest 2003; 123:953-6.
8. Brost BC, Newman RB. The maternal and fetal effects of tuberculosis therapy. Obstet Gynecol Clin North Am 1997; 24:659-73.
9. Kahlmeter G, Dahlager JI. Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982. J Antimicrob Chemother 1984; 13(Suppl A):9-22.
10. Bucco T, Meligrana G, De Luca V. Neurotoxic effects of cycloserine therapy in pulmonary turberculosis of adolescents and young adults. Scand J Respir Dis 1970; 71(Suppl):259-65.
11. Helmy B. Side effects of cycloserine. Scand J Respir Dis 1970; 71 (Suppl):220-5.
12. Gupta DK. Acceptability of thionamides. I. Ethionamide. J Postgrad Med 1977; 23:175-80.
13. Holdiness M. Clofazimine in pregnancy. Early Hum Dev 1989; 18:297-8.
14. National Center for Health Statistics. Clinical growth charts. Available at: http://www.cdc.gov/nchs/about/major/nhanes/growthcharts/clinical _charts. htm. Accessed 15 October 2004.
15. Schaefer G, Zervoudakis IA, Fuchs FF, David S. Pregnancy and pulmonary tuberculosis. Obstet Gynecol 1975; 46:706-15.
16. Enarson DA, Rieder HL, Arnodottir T, Trebucq A. Tuberculosis guide for low income countries. 4th ed. Paris: International Union against Tuberculosis and Lung Diseases, 1996.
17. Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 1998; 53:536-48.
18. Miller KS, Miller JM. Tuberculosis in pregnancy: interactions, diagnosis, and management. Clin Obstet Gynecol 1996; 39:120-42.
19. Bothamley G. Drug treatment for tuberculosis in pregnancy: safety considerations. Drug Safety 2001; 24:553-65.
20. World Health Organization (WHO). Treatment of tuberculosis: guidelines for national programmes. 3rd ed. Geneva: WHO, 2003.
21. Good JT, Iseman MD, Davidson PT, et al. Tuberculosis in association with pregnancy. Am J Obstet Gynecol 1981; 140:492-8.
22. Nitta A, Milligan D. Management of four pregnant women with multidrug-resistant tuberculosis. Clin Infect Dis 1999; 28:1298-304.
23. Starke JR. Tuberculosis: an old disease but a new threat to the mother, fetus and neonate. Clin Perinatol 1997; 24:107-27.
24. Jana N, Vasishta K, Jindal SK, Khunnu B, Ghosh K. Perinatal outcomes in pregnancies complicated by pulmonary tuberculosis. Int J Gynaecol Obstet 1994; 44:119-24.
25. Figueroa-Damian R, Arredondo-Garcia JL. Neonatal outcome of children born to women with tuberculosis. Arch Med Res 2001; 32:66-9.
26. Jana N, Vasishta K, Saha SC, Ghosh K. Obstetrical outcomes among women with extrapulmonary tuberculosis. N Engl J Med 1999; 341:645-9.
27. Cantwell MF, Shehab ZM, Cosello AM, et al. Brief report: congenital tuberculosis. N Engl J Med 1994; 330:1051-4.
28. Adhikari M, Pillay T, Pillay DG. Tuberculosis in the newborn: an emerging disease. Pediatr Infect Dis J 1997; 16:1108-12.
29. Starke JR, Jacobs RF, Jereb J. Resurgence of tuberculosis in children. J Pediatr 1992; 120:839-55.
30. Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the prechemotherapy era. Int J Tuberc Lung Dis 2004; 8:392-402.